The E-cadherin adhesion molecule and colorectal cancer. A global literature approach

E Tsanou, D Peschos, A Batistatou… - Anticancer …, 2008 - ar.iiarjournals.org
The E-cadherin-catenin complex plays a crucial role in epithelial cell cell adhesion and in
the maintenance of tissue architecture. Down-regulation of E-cadherin expression correlates …

[HTML][HTML] What we could do now: molecular pathology of colorectal cancer

RS Houlston - Molecular Pathology, 2001 - ncbi.nlm.nih.gov
The contribution of molecular genetics to colorectal cancer has been largely restricted to
relatively rare inherited tumours and to the detection of germ line mutations predisposing to …

Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papilloma virus tumor status

MR Mullokandov, NG Kholodilov, NB Atkin, RD Burk… - Cancer research, 1996 - AACR
Specific human papilloma virus (HPV) types appear to be necessary etiological factors for
most cervical cancers, yet additional genetic alterations seem to be required for their …

Characterization of the DiFi rectal carcinoma cell line derived from a familial adenomatous polyposis patient

M Olive, S Untawale, RJ Coffey, MJ Siciliano… - In Vitro Cellular & …, 1993 - Springer
The DiFi human colorectal cancer cell line was recently established from a familial
adenomatous polyposis patient with extracolonic features characteristic of the Gardner …

Molecular genetics of colon cancer

I Tomlinson, M Ilyas, M Novelli - Cancer and Metastasis Reviews, 1997 - Springer
Colorectal cancer remains a major health problem. Few therapies are effective apart from
surgery, and survival has increased little in recent years. This is despite the fact that …

An Src-protein tyrosine kinase inhibitor to reduce cisplatin ototoxicity while preserving its antitumor effect

EC Bielefeld, C Tanaka, D Coling, M Li… - Anti-cancer …, 2013 - journals.lww.com
Ototoxicity remains a major dose-limiting side effect of cisplatin. The current studies were
carried out to evaluate the effectiveness of a novel Src-protein tyrosine kinase inhibitor in …

Loss of heterozygosity in clinical stage IB cervical carcinoma: relationship with clinical and histopathologic features

PC Huettner, DS Gerhard, L Li, DJ Gersell, K Dunnigan… - Human pathology, 1998 - Elsevier
Loss of heterozygosity (LOH) has been shown to be an important prognostic factor in a
variety of malignant neoplasms. The relationship between LOH and established …

A specific genetic alteration on chromosome 6 in ulcerative colitis-associated colorectal cancers

T Ezaki, M Watanabe, N Inoue, T Kanai, H Ogata… - Cancer research, 2003 - AACR
Various genetic alterations in ulcerative colitis (UC)-associated colorectal cancers (CRCs)
have been reported. However, almost all studies have shown abnormalities of the known …

Genetic prognostic markers in colorectal cancer.

RS Houlston, IP Tomlinson - Molecular Pathology, 1997 - ncbi.nlm.nih.gov
The contribution of molecular genetics to colorectal cancer has been restricted largely to
relatively rare inherited tumours and to the detection of germline mutations predisposing to …

Recurrent deletions at 6q in early age of onset non‐HNPCC‐and non‐FAP‐associated intestinal carcinomas. Evidence for a novel cancer susceptibility locus at 6q14 …

H Bläker, G Mechtersheimer, C Sutter… - Genes …, 2008 - Wiley Online Library
Hereditary intestinal cancers mainly occur in the framework of the familial adenomatous
polyposis (FAP) and hereditary nonpolyposis colorectal cancer (HNPCC) syndromes …